| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/ANNONC/MDI812 |
| P698 | PubMed publication ID | 15888740 |
| P50 | author | David Cunningham | Q38803238 |
| P2093 | author name string | J Oliveira | |
| ESMO Guidelines Task Force | |||
| L M Jost | |||
| G Purkalne | |||
| P433 | issue | suppl_1 | |
| P304 | page(s) | i22-3 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of gastric cancer | |
| P478 | volume | 16 Suppl 1 |
| Q28485310 | A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers |
| Q37234171 | A phase II study of leucovorin, 5-FU and docetaxel combination chemotherapy in patients with inoperable or postoperative relapsed gastric cancer |
| Q36215991 | A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate? |
| Q36037976 | Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer |
| Q85048349 | Gastric cancer–related information on the Internet: incomplete, poorly accessible, and overly commercial |
| Q37699416 | Identification of aberrantly expressed glycans in gastric cancer by integrated lectin microarray and mass spectrometric analyses |
| Q40100079 | Lentivirus-mediated RNA interference targeting E2F-1 inhibits human gastric cancer MGC-803 cell growth in vivo |
| Q47146130 | MerTK is a novel therapeutic target in gastric cancer |
| Q35902144 | Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells |
| Q34962091 | Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy. |
| Q84364338 | Recommendations on current approach to gastric cancer |
| Q55069791 | The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer. |
| Q33631305 | Treatment-related severe and fatal adverse events with molecular targeted agents in the treatment of advanced gastric cancer: a meta-analysis |
| Q33594943 | Use of lectin microarray to differentiate gastric cancer from gastric ulcer |
| Q39352798 | siRNA targeting of Cdx2 inhibits growth of human gastric cancer MGC-803 cells |
Search more.